COO Puts $5M Into Uber Stock

UBER President and COO Andrew Gordon MacDonald filed on 8 September showing two open-market purchases made on 4 September. Combined, the two trades total around $5.3 million at prices near $75.65 and $76.44 per share. That is a meaningful personal commitment for a sitting operating chief. Discretionary buying by a named C-level executive carries a stronger signal than a routine award or option exercise.

Two directors at HELP Helus Pharma also filed purchases on the same date. Eric So bought 100,000 shares for roughly $1.2 million. Paul Glavine bought the same number a day earlier for $1.18 million. Two board members buying within 24 hours of each other is a cluster worth noting.

Outside the US, Nippon Paper Industries filed a $397 million sale of shares in LINTEC, the Japanese adhesive materials group, where it holds a main-shareholder board seat. That is a large strategic unwind and suggests Nippon Paper is exiting the position. Separately, Fosun Pharma's subsidiary disclosed a combined $296 million reduction in its GLAND Pharma stake through two tranches, the second of which stood at $229 million.

The Korean robotics sector saw its own filing of note. Kim Byeong Soo, CEO of ROBOTIS, filed a sale worth $75 million on 8 September. No plan disclosure accompanied the filing, though the size merits attention in a sector that has seen elevated valuations.